RIPK4 and breast cancer: Consistent with the results from the qRT-PCR analysis, western blotting showed higher levels of RIPK4 in 86.7% (13/15) of human primary BC tissues compared its level in the matched non-cancerous tissues from the same patients (Fig. 1c).